Bevacizumab Biosimilar, Human VEGF Monoclonal Antibody. Bevacizumab biosimilar CHO stable cell line is available for licensing to manufacture the bevacizumab biosimilar protein.The research grade bevacizumab biosimilar protein is for research use only (RUO). Recombinant human...
Bevacizumab Biosimilar, N297A Mutant. Bevacizumab biosimilar CHO stable cell line is available for licensing to manufacture the bevacizumab biosimilar protein.The research grade bevacizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...
Bevacizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Bevacizumab biosimilar CHO stable cell line is available for licensing to manufacture the bevacizumab biosimilar protein.The research grade bevacizumab biosimilar protein is for research use only...
Felvizumab Biosimilar, RSV Monoclonal Antibody. The research grade Felvizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...
Alemtuzumab Biosimilar, Human CD52 Monoclonal Antibody. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Abciximab Biosimilar, Glycoprotein IIb/IIIa Receptor Monoclonal Antibody. The research grade abciximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Ramucirumab Biosimilar, Human VEGFR2 Monoclonal Antibody. The research grade ramucirumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Secukinumab Biosimilar, Human IL17A Monoclonal Antibody. The research grade Secukinumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Eculizumab Biosimilar, Human C5 Monoclonal Antibody. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab biosimilar protein is for research use only (RUO). Recombinant...
